Journey Medical Corporation (DERM) vs Siga Technologies Inc. (SIGA)

Journey Medical Corporation and Siga Technologies Inc. are both Drug Manufacturers Specialty & Generic companies. Siga Technologies Inc. is the larger, with a market value of $229.2M against $144.7M — 1.6× the size. Journey Medical Corporation grew revenue faster over the last twelve months: 20.9% against −70.1%. Siga Technologies Inc. has the higher net margin (−5.19% vs −8.95%) and the lower return on invested capital (−14.6% vs −5.89%). Across the 19 metrics below, Journey Medical Corporation leads on 10 and Siga Technologies Inc. on 9.

Valuation

Metric DERM SIGA Drug Manufacturers Specialty & Generic median
P/E n/m n/m 19.25
P/S 2.00 4.24 2.11
P/B 4.26 1.38 1.78
Price to free cash flow n/m n/m 16.14
EV/EBITDA 78.30 n/m 12.58
EV/Sales 2.00 5.01 2.73
Earnings yield (4.43%) (1.26%) (4.38%)
Free cash flow yield (16.46%) (9.02%) 0.00%

Profitability

Metric DERM SIGA Drug Manufacturers Specialty & Generic median
Gross margin 65.45% 54.35% 53.94%
Operating margin (4.41%) (20.76%) 0.00%
Net margin (8.95%) (5.19%) 0.00%
Free cash flow margin (10.99%) (37.58%) 0.00%
Return on equity (23.77%) (1.49%) (0.40%)
Return on assets (6.80%) (1.36%) (3.32%)
Return on invested capital (5.89%) (14.59%) 0.00%

Growth

Metric DERM SIGA Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 20.89% (70.13%) 10.01%
EPS growth (last fiscal year) 34.72% (60.98%) 49.06%
Revenue growth, 5-year CAGR 6.79% (5.42%) 6.74%
Net income growth, 5-year CAGR 0.00% (16.20%) 0.00%

Health

Metric DERM SIGA Drug Manufacturers Specialty & Generic median
Debt to equity 0.79 0.00 0.05
Current ratio 1.59 21.72 2.31
Net debt to EBITDA (0.35) (6.39) 0.97

Dividend

Metric DERM SIGA Drug Manufacturers Specialty & Generic median
Dividend yield — 0.00% 1.57%
Payout ratio — — 0.27

Size

Metric DERM SIGA Drug Manufacturers Specialty & Generic median
Market cap 144.65m 229.20m 276.90m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack